Cell Biology · Skim version

Cytoskeletal Polymers and Dynamics

About 2 min to skim · 3 figures · Rewritten on

Read the full lesson → Skim the whole course →

The guiding idea

A microtubule in a dish of pure tubulin grows for minutes, then collapses many times faster. Why would a polymer be built to fail? Because a polymer that switches by itself lets a cell explore space, rebuild its scaffolding and organize division.

Cells keep their cytoskeleton in constant, regulated turnover so they can explore space, change shape, move and build the division spindle.

From the film: Tight Ends, Loose Ends

  • Each filament end has a critical concentration: above it the end grows, below it the end shrinks.
  • If subunits never hydrolysed their nucleotide, both ends would share one critical concentration and the polymer would simply settle.
  • Hydrolysis after joining gives a polymer tight ends, with a low critical concentration, and loose ends, with a high one.
  • At treadmilling steady state, actin grows at its tight barbed end and shrinks at its loose pointed end.
  • A microtubule end is tight while it keeps its GTP cap and collapses many times faster when it loses it.

From the film: When a Drug Becomes a Test

  • A drug tests a mechanism only when its target, dose and test system stay attached.
  • The same change in polymer amount can begin at free subunits, filament ends or the lattice.
  • Latrunculin A sequesters actin monomers and can also speed loss at the ends of freshly built filaments.
  • Nocodazole effects depend on dose and on the cultured cell system.
  • A second measurement can separate mechanisms that produce the same outcome.
  1. Three polymers built for different jobs

    AI-generated illustration: three filament segments side by side at the same scale; a thin actin filament with an arrowhead end, a thick hollow microtubule with a plus end, and a rope-like intermediate filament built from antiparallel tetramers.
    Three polymers drawn to the same scale. Actin and microtubules have two different ends; the intermediate filament's building block points both ways, so its two ends are alike. AI-generated illustration
  2. One end: the doorway and its critical concentration

  3. Two ends: why hydrolysis makes them differ

    AI-generated illustration: a ten-bead actin filament with a new bead joining at the barbed end and an older bead leaving the pointed end, a broad arrow showing subunits flowing front to back, and a second strip showing the same length a moment later.
    Treadmilling: at steady state the barbed end gains subunits as fast as the pointed end loses them, so the filament keeps its length while subunits flow through it. AI-generated illustration
  4. One end, two states: dynamic instability

  5. Drugs as tests

    AI-generated illustration: on the left, a cutaway microtubule lattice with a yellow tag inside the wall facing the lumen labelled taxol, and free tubulin dimers beside it with a pink tag labelled colchicine and nocodazole; on the right, a beaded actin filament with a yellow tag along its side labelled phalloidin, a pink tag at one end labelled cytochalasin B, and loose actin monomers, one with a pink tag labelled latrunculin A.
    Where each drug binds: taxol inside the assembled lattice, facing the lumen, colchicine and nocodazole on free tubulin dimers, phalloidin along actin filaments, cytochalasin B at their ends, latrunculin A on actin monomers. Effects depend on dose and system. AI-generated illustration
  6. Going deeper

Read the full lesson → Skim the whole course →